Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 Zannes Timothy P A - Award D 8,641
2025-01-10 BIAF / bioAffinity Technologies, Inc. 4 GIRGENTI STEVEN A - Award D 14,814
2025-01-06 INCY / Incyte Corporation 4 Issa Mohamed Khairie A - Award D 48,671
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 2,850
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 1,518
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 2,338
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 11,819
2025-01-02 LUNA / Luna Innovations Incorporated 4 ANDERSON N LEIGH M - Exercise D 1,344
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 745
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 946
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 1,139
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 740
2025-01-02 LUNA / Luna Innovations Incorporated 4 SPIEGEL GARY M - Exercise D 7,102
2025-01-02 NRC / National Research Corporation 4 Hays Michael D. M - Exercise D 13.17 10,014
2025-01-01 NEO / NeoGenomics, Inc. 4 Harris Melody F - Taxes D -7,070
2024-12-31 MEDP / Medpace Holdings, Inc. 4 Kraft Robert O. M - Exercise D 71
2024-12-31 MEDP / Medpace Holdings, Inc. 4 McCarthy Cornelius P. III M - Exercise D 62
2024-12-31 MEDP / Medpace Holdings, Inc. 4 Carley Brian T M - Exercise D 78
2024-12-31 NRC / National Research Corporation 4 Common Property Trust By Amandla, LLC G - Gift I 4,755,317
2024-12-31 NRC / National Research Corporation 4 Amandla MK Trust By Amandla, LLC G - Gift I -4,755,317
2024-12-31 INCY / Incyte Corporation 4 HARRIGAN EDMUND A - Award D 69.07 339
2024-12-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 446
2024-12-31 INCY / Incyte Corporation 4 BAKER BROS. ADVISORS LP See Footnotes A - Award I 446
2024-12-31 INCY / Incyte Corporation 4 Clancy Paul J A - Award D 69.07 331
2024-12-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 4.007 -3,000
2024-12-26 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.932 3,000
2024-12-20 LUNA / Luna Innovations Incorporated 4 Coe Pamela L M - Exercise D 13,372
2024-12-19 NOTV / Inotiv, Inc. 4 Landman David P - Purchase D 4.25 23,529
2024-12-16 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 69.31 -650
2024-12-13 INCY / Incyte Corporation 4 Tray Thomas S - Sale D 70.64 -650
2024-12-10 NOTV / Inotiv, Inc. 4 Beattie John Gregory P - Purchase D 4.75 30,000
2024-12-10 NOTV / Inotiv, Inc. 4 Brown Nigel P - Purchase D 4.26 7,500
2024-12-09 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 4.13 -13,634
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.791 -2,495
2024-12-09 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 4.13 -23,871
2024-12-09 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 4.13 -8,022
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.932 483
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 1.641 1,121
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 891
2024-12-09 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 72.11 -873
2024-12-09 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 72.11 -1,510
2024-12-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 46,501
2024-12-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 26,555
2024-12-07 OABI / OmniAb, Inc. 4 Berkman Charles S M - Exercise D 15,621
2024-12-07 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -11,746
2024-12-06 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.701 -505
2024-12-06 NOTV / Inotiv, Inc. 4 Landman David P - Purchase D 4.14 100,000
2024-12-06 NOTV / Inotiv, Inc. 4 Harrington Michael J P - Purchase D 3.9822 10,000
2024-12-06 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 505
2024-12-06 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J M - Exercise D 32.05 15,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)